Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty - Mazurov, A V; Pevzner, D V; Antonova, O A (Platelets, 2002)
, et al.